HAI Book 2025 - Flipbook - Page 34
Board
#
Presenter
Day
Callow, Daniel
Wednesday
28
Capotosti,
Francesca
Wednesday
02
Wednesday
15
Friday
152
Chan, Tevy
Friday
168
Chen, Charles
Thursday
110
Clarke, Mica
Wednesday
33
Cody, Karly
Wednesday
22
Cody, Karly
Friday
133
Cassa Macedo,
Arthur
Cassa Macedo,
Arthur
Colón-Badillo,
Vanessa
CorriveauLecavalier, Nick
Del Carmen
Montenegro, Grace
Wednesday
11
Wednesday
09
Wednesday
38
DelBene, Alexander
Wednesday
29
Dhaynaut, Maeva
Wednesday
35
Diez, Ibai
Wednesday
45
Dodge, Hiroko
Wednesday
53
Dong, Yiwen
Wednesday
19
Dubbelman, Mark
Wednesday
01
Duggan, Michael
Wednesday
14
Ekuta, Victor
Wednesday
08
Engels-Domínguez,
Nina
Wednesday
34
Poster Title
Amyloid status moderates associations between
hippocampal microstructure, PET tau burden, and memory
in dementia-free older adults
From the clinical utility of a-synuclein PET imaging in
Multiple System Atrophy to the possible diagnosis of
Parkinson9s disease
The spatial spread of tauopathy precedes the increase in
tau-PET load in Alzheimer9s disease
Head-to-head comparison of four tau-PET tracers for in
vivo Braak staging: the HEAD Study
Clinical validation of the Lumipulse G1200 automated
immunoassay for the measurement of Alzheimer9s disease
plasma biomarkers
Two distinct sources of 18F-MK-6240 off-target signal
identified by individualized head modeling and PET kinetics
Molecular imaging of neurodegeneration 3 mitochondria,
associated proteins and synapses (MIND-MAPS) in
frontotemporal dementia
The relative prevalence of tau severity stages is related to
amyloid burden, clinical diagnosis and age
Effects of amyloid and tau status on multiplex plasma CNS
and inflammatory proteins in a normal aging cohort
Targeted plasma eQTL and pQTL to identify potential novel
biomarker for Alzheimer's Disease in African Americans
Characterization of a limbic-predominant amnestic
neurodegenerative syndrome
Validation of PET spatial extent as sensitive amyloid
biomarker in early stages of amyloidosis
Performance of an MR-independent analysis pipeline for
quantification of tau abnormality using [18F]flortaucipir PET
Cerebral perfusion indices from early-phase [18F]-MK6240
dynamic Tau PET imaging in brain regions associated with
Alzheimer9s Disease progression in an aging population.
Unveiling the heterogeneity of tau spreading in aging and
Alzheimer's disease using polygenic combinations: Towards
personalized models
Combined impact of plasma phospho-tau 217 and NfL on
longitudinal domain-specific cognitive decline
The association between amyloid and physical activity in a
racially diverse cohort of older adults
Decline in everyday functioning over time relates to amyloid
and tau in cognitively unimpaired older adults
Proteomic analyses of A-T-N reveal plasma mediators of
neurodegeneration and dementia risk
Understanding the impact of race on white matter
hyperintensities in Alzheimer9s disease: Findings from the
ADNI Study
Evaluating tVNS effects on cognitive outcomes and
modulating factors in asymptomatic older adults: study
design of the WALLe Trial
HAI2025 - 34
